These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16447127)

  • 1. An unjustifiably alarming report of a fatal case of retroviral rebound syndrome.
    Angel-Moreno A; Perez-Arellano JL
    Clin Infect Dis; 2006 Mar; 42(5):732-3; author reply 733. PubMed ID: 16447127
    [No Abstract]   [Full Text] [Related]  

  • 2. [HIV and antiretroviral therapy: in every 3rd patient a virus rebound takes place].
    Kunde K
    Dtsch Med Wochenschr; 2000 Aug; 125(33):A10. PubMed ID: 11023348
    [No Abstract]   [Full Text] [Related]  

  • 3. Multidrug-resistant HIV-1.
    Tayloe D
    Clin Infect Dis; 2004 May; 38(10):1507; author reply 1507. PubMed ID: 15156500
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral load testing in resource-limited settings.
    Schooley RT
    Clin Infect Dis; 2007 Jan; 44(1):139-40. PubMed ID: 17143830
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe acute hepatitis due to retroviral rebound syndrome after discontinuation of highly active antiretroviral therapy.
    Zavascki AP
    J Infect; 2006 Mar; 52(3):e93-4. PubMed ID: 16026841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to antiretroviral therapy: how much is enough?
    Gulick RM
    Clin Infect Dis; 2006 Oct; 43(7):942-4. PubMed ID: 16941381
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

  • 8. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
    [No Abstract]   [Full Text] [Related]  

  • 9. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
    Wepner U
    MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV eradication--facts and fiction].
    Jaeger H; Wolf E
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral load and transmission.
    AIDS Patient Care STDS; 2000 Apr; 14(4):227. PubMed ID: 10806649
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-1 load quantitation: a 17-year perspective.
    Holodniy M
    J Infect Dis; 2006 Sep; 194 Suppl 1():S38-44. PubMed ID: 16921471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance screening].
    Sierra S; Lengauer T; Kaiser R
    MMW Fortschr Med; 2009 Apr; 151(18):72, 74-5. PubMed ID: 19769083
    [No Abstract]   [Full Text] [Related]  

  • 15. Three-class-resistant human immunodeficiency virus type 1 variant in a drug-naive heterosexual couple.
    Razzolini F; Saladini F; Malincarne L; Vicenti I; Palladino N; Romano L; Francisci D; Zazzi M
    J Clin Microbiol; 2008 Nov; 46(11):3856-9. PubMed ID: 18845824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
    Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
    J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.
    Glass TR; De Geest S; Hirschel B; Battegay M; Furrer H; Covassini M; Vernazza PL; Bernasconi E; Rickenboch M; Weber R; Bucher HC;
    Antivir Ther; 2008; 13(1):77-85. PubMed ID: 18389901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment interruptions in HIV-infected subjects.
    Bongiovanni M; Casana M; Tincati C; d'Arminio Monforte A
    J Antimicrob Chemother; 2006 Sep; 58(3):502-5. PubMed ID: 16816398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventing rebound viremia after ending ART. Long-term control].
    Bischoff A
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():10. PubMed ID: 25026845
    [No Abstract]   [Full Text] [Related]  

  • 20. Designing and interpreting HIV noninferiority trials in naive and experienced patients.
    Hill A; Sabin C
    AIDS; 2008 May; 22(8):913-21. PubMed ID: 18453850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.